Where Will Vertex Pharmaceuticals Be in 10 Years?
Vertex Pharmaceuticals (NASDAQ: VRTX) has come a long way in the past ten years. In a little over a decade, the company has built a cystic fibrosis (CF) empire, commercializing four drugs for the disease that together generate blockbuster revenue . And the share price has soared more than 400%, scoring a big win for long-term investors.
Now, whether you're a Vertex investor or a potential one, you may be wondering what's next for this big biotech. The company recently started its expansion beyond CF with a U.K. regulatory nod for exa-cel, a gene-editing treatment for blood disorders. And Vertex has several candidates across treatment areas in the pipeline. Where will the company be in 10 years? Let's find out.
Image source: Getty Images.
Source Fool.com
Vertex Pharmaceuticals Inc. Stock
With 60 Buy predictions and 2 Sell predictions Vertex Pharmaceuticals Inc. is one of the favorites of our community.
As a result the target price of 450 € shows a slightly positive potential of 4.86% compared to the current price of 429.15 € for Vertex Pharmaceuticals Inc..
